| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/02/2005 | WO2004024894A3 Methods of modulating inflammation by administration of interleukin-19 and inhibitors of il-19 binding |
| 06/02/2005 | WO2004007689A3 Regulatory protein for nox enzymes |
| 06/02/2005 | WO2003090514A3 Adipocyte complement related protein zacrp14 |
| 06/02/2005 | WO2003087375A8 Cartilage differentiation regulating gene |
| 06/02/2005 | WO2003070823A9 Conjugates comprising a biodegradable polymer and uses therefor |
| 06/02/2005 | WO2003059253A3 Compositions and methods for altering glucose production |
| 06/02/2005 | WO2003057821A3 Mut-il-18 or mut-il-18r proteins, antibodies, compositions, methods and uses |
| 06/02/2005 | WO2003040161A3 Antisense modulation of activating transcription factor 3 expression |
| 06/02/2005 | WO2002088320A3 Raav-vectored ribozyme compositions and methods for the treatment of retinal diseases |
| 06/02/2005 | US20050120409 Expression vector comprising nucleotide sequences coding hypersensitive response eliciting protein for use in generating disease, insect, drought and heat resistant plants; biological pest control |
| 06/02/2005 | US20050120398 Animal model for HCV infection |
| 06/02/2005 | US20050120397 Preventing spermatid differentiation via inhibition of caspase expression; gene expression inhibition; biological pest control; contraceptives; infertility treatment; male contraception |
| 06/02/2005 | US20050119712 An implant containing an electrical signal generator, a pump, and a reservoir containing stem cell enhancers for proliferation, migration, differentiation, or integration of endogenous stem cells of the central nervous system; Alzheimer's and Parkinson's Diseases, spinal cord injury, stroke |
| 06/02/2005 | US20050119502 (Dialkylamino, morpholino, or imidazolyl)-alkoxyphenolic derivatives as drug delivery agents; improved bioavailability for oral administration |
| 06/02/2005 | US20050119472 GB virus C and methods of treating viral infections |
| 06/02/2005 | US20050119465 Glycosylated follicle stimulating hormone for use as therapeutic tool in treatment of reproductive disorders |
| 06/02/2005 | US20050119464 Protein |
| 06/02/2005 | US20050119459 Expression vector comprising nucleotide sequences coding late-gestation lung 1 (LGL-1) for use as tool in diagnosis prevention and treatment of respiratory system disorders |
| 06/02/2005 | US20050119458 Transport protein for use in identifying modulator for prevention and treatment of cell proliferative, skin and psychological disorders; anticonvulsants; insecticides; pesticides; anthelmintics |
| 06/02/2005 | US20050119457 Human proteins |
| 06/02/2005 | US20050119453 Method of removing transition metals |
| 06/02/2005 | US20050119323 Hormone sensitive vcancer; antiproliferative agents ; induction apoptosis; angiotensin inhibitors |
| 06/02/2005 | US20050119259 Synergistic mixture of anticoagulant and antiarrhythmia agents |
| 06/02/2005 | US20050119212 Controlling gene expression; spinal cord injuries |
| 06/02/2005 | US20050119211 Moderators of gene expression; mixture of small nucleic acids |
| 06/02/2005 | US20050119210 Using genes encoding transmembrane protein as markers; targets for cancer therapy; drug screening |
| 06/02/2005 | US20050119209 Compositions and methods for the treatment and diagnosis of immune disorders |
| 06/02/2005 | US20050119208 Composition and method for treating lupus nephritis |
| 06/02/2005 | US20050119207 Administering an agents, such as antibody,which prevents gene expresion; analgesics; anesthetics |
| 06/02/2005 | US20050119206 Cg8327, cg10823, cg18418, cg15862, cg3768, cg11447 and cg16750 homologous proteins involved in the regulation of energy homeostasis |
| 06/02/2005 | US20050119205 Methods of modulating heme oxygenase-1 expression and treating heme oxygenase-1 mediated conditions |
| 06/02/2005 | US20050119203 Smad7 inhibitors for the treatment of cns diseases |
| 06/02/2005 | US20050119202 Medicament to treat a fibrotic disease |
| 06/02/2005 | US20050119190 Anticoagulants; cardiovascular disorders; thrombosis |
| 06/02/2005 | US20050119189 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 06/02/2005 | US20050119188 Method of treating breast cancer |
| 06/02/2005 | US20050119187 Anti-fibril peptides |
| 06/02/2005 | US20050119186 Potent peptide inhibitors and methods of use |
| 06/02/2005 | US20050119185 Anticancer agents ; leukemia |
| 06/02/2005 | US20050119184 Immunoregulator |
| 06/02/2005 | US20050119183 Method for treating bone loss using parathyroid hormone |
| 06/02/2005 | US20050119181 Hydrophobically-modified protein compositions and methods |
| 06/02/2005 | US20050119180 Use of angiotensin 1-7 for enhancing cardiac function |
| 06/02/2005 | US20050119179 Inositol 1, 4, 5-triphosphate receptor (type 1), phosphorylation and modulation by CDC2 |
| 06/02/2005 | US20050119178 Insulinotropic hormone derivatives and uses thereof |
| 06/02/2005 | US20050119177 Using diketopiperazine; graft versus host disease; autoimmune disease; multiple sclerosis; skin disorders; antiarthritic agents; pancreatitis; inflamamtory bowel disorders |
| 06/02/2005 | US20050119176 Core structure polypeptide; libraries; inhibition of apoptosis; anticancer agents; autoimmune disease; skin disorders; restenosis |
| 06/02/2005 | US20050119175 Method for stimulating wound healing |
| 06/02/2005 | US20050119171 Forsenic analysis; medical diagnosis; chromosome markers |
| 06/02/2005 | US20050119170 Therapy for anaphylactic shock |
| 06/02/2005 | US20050119169 Spatially-defined macrocycles incorporating peptide bond surrogates |
| 06/02/2005 | US20050119168 Macrocyclic inhibitors of hepatitis C virus NS3-serine protease |
| 06/02/2005 | US20050119167 Process for the preparation of cyclic peptides |
| 06/02/2005 | US20050119166 Complex of cytotoxic agent with aoligopeptide; amino acid sequence proteolytic splitting prostate specific antigen; prostate cancer; benign prostatic hyperplasia |
| 06/02/2005 | US20050119165 Vascular endothelial growth factor dimers |
| 06/02/2005 | US20050119164 Immunomodulatory polymeric antigens for treating inflammatory pathogies |
| 06/02/2005 | US20050119163 Prevent binding to phosphoprotein; cancer therapy; angiogenesis inhibitor |
| 06/02/2005 | US20050119162 Anxiolytic agents; using transferrins; quality of life for cancer patients; antiarthritic agents; antiinflammatory agents; compaction; uniform particle size |
| 06/02/2005 | US20050119161 Methods and compositions for oxygen transport comprising an oxygen carrier and a crystalloid in hypertonic solution |
| 06/02/2005 | US20050119160 Administering pyrimidopyrimidine compound such as dipyridamole with methotrexate or aspirin |
| 06/02/2005 | US20050119159 Remedy for ischemic heart failure |
| 06/02/2005 | US20050118717 delivering to microtubules a microtubule binding substance, such as taxol, that is coupled to a herpes simplex virus 1 VP22 protein; may be used pharmaceutically to retard or arrest cell division of cells such as neoplastic cells or protozoal parasite cells in vitro or in vivo. |
| 06/02/2005 | US20050118698 Propagating viral particle in BHK (baby hamster kidney) and MDCK (mandine darby canine kidney) cell lines; for use as bioreactor for producing drugs and/or diagnostic agents |
| 06/02/2005 | US20050118684 Recombinant antihemophilic factor for use as tool in treatment hemophilia |
| 06/02/2005 | US20050118682 Using transgenic animal to prepare osteoclastogenesis inhibitory factor (OCIF) for use in treatment of osteoporosis |
| 06/02/2005 | US20050118681 Transcription factor for use as regulatory tool in expression of musculin; treatment and prevention of myogenic cancers |
| 06/02/2005 | US20050118680 Human chemotactic protein |
| 06/02/2005 | US20050118679 Novel metalloproteinases |
| 06/02/2005 | US20050118678 Modified polypeptide comprising amphipathic alpha -helical structure for use in prevention and treatment of infection and cell proliferative disorders |
| 06/02/2005 | US20050118677 CC chemokine receptor 5 DNA, new animal models and therapeutic agents for HIV infection |
| 06/02/2005 | US20050118676 Gene therapy vectors having reduced immunogenicity |
| 06/02/2005 | US20050118675 Heptahelix receptor and its use as leukotriene B4 receptor |
| 06/02/2005 | US20050118672 Using peptide: N-Glycosidase F (PNGase-F) to generate glycopeptide with uniform glycosylation patterns |
| 06/02/2005 | US20050118661 Fibronectin variants and screening methods |
| 06/02/2005 | US20050118656 Methods for diagnosis and treatment of epithelial-derived cancers |
| 06/02/2005 | US20050118645 Prion specific immunogllobulin for detection, diagnosis and prevention of spongiform encephalopathies; immunotherapy |
| 06/02/2005 | US20050118638 Using thyrotrophin (TSH) receptor as diagnostic tool in detection of autoimmune diseases; competive binding assay |
| 06/02/2005 | US20050118635 Using cytoskeletal membrane protein concentration as diagnostic indicator of cell proliferative disorders; antitumor agents |
| 06/02/2005 | US20050118629 antibody to polypeptide containing a fragment capable of binding to and inducing apoptosis in a carcinoma cell; Tumor Necrosis Factor Related ligand or "TRELL", a polypeptide which is a member of the Tumor Necrosis Factor Family |
| 06/02/2005 | US20050118615 Chordin-like homologs |
| 06/02/2005 | US20050118598 Polypeptides derived from fibrinogen; modified by cyclization; antiangiogenic; transgenic cells, animals |
| 06/02/2005 | US20050118597 Peptide II |
| 06/02/2005 | US20050118594 Enzymes |
| 06/02/2005 | US20050118585 Using allelic variation in bone morphogenic signaling family proteins as diagnostic tool in detection of vision defcets |
| 06/02/2005 | US20050118581 Novel brain expressed gene and protein associated with bipolar disorder |
| 06/02/2005 | US20050118579 Using allelic variation in canalicular multispecific organic anion transporter (cMOAT) gene as diagnostic tool in detection of liver and bile duct disorders |
| 06/02/2005 | US20050118573 Nucleic sequence and deduced protein sequence family with human endogenous retroviral motifs, and their uses |
| 06/02/2005 | US20050118292 Dioscorea extracts |
| 06/02/2005 | US20050118277 Protective factors against inflammation, burns and noxious stimuli |
| 06/02/2005 | US20050118274 cells are combined into capsule units by means of an enveloping substance which surrounds the cells; order to prevent coagulation or rejection, coagulation-inhibiting agents or coagulation-preventing structures are placed in or on the enveloping substance; liver bioreactor |
| 06/02/2005 | US20050118271 Polytartrate composition |
| 06/02/2005 | US20050118254 hydrophilic solvent, an oil, and a surfactant, and a pharmaceutically active component; hydrophilic solvent selected from the group consisting of propylene glycol diacetate, propylene glycol monoacetate, and salts |
| 06/02/2005 | US20050118253 comprising a nucleic acid that is fully encapsulated within a lipid; for treating a neoplasia in a mammal |
| 06/02/2005 | US20050118230 Methods and compositions for regenerating connective tissue |
| 06/02/2005 | US20050118227 Hydrazide compounds with angiogenic activity |
| 06/02/2005 | US20050118206 A surfactant, a solvent, and a beneficial agent; exposure to a hydrophilic environment, surfactant and solvent form a viscous gel and beneficial agent dispersed or dissolved in the gel; |
| 06/02/2005 | US20050118204 Methods for controlling membrane permeability of a membrane permeable substance and screening methods for a membrane permeable substance |
| 06/02/2005 | US20050118196 Novel therapeutic processes for establishing or enhancing an immunized state, and compositions useful therefor |
| 06/02/2005 | US20050118195 Virus causing respiratory tract illness in susceptible mammals |
| 06/02/2005 | US20050118194 Oral vaccine, method for its preparation and use thereof |